Our clinic is following PPE precautions & maintaining social distancing

English Espanol

Nikhil Nalluri M.D.

Interventional Cardiologist & Endovascular Specialist in Dallas and Desoto
Nikhil Nalluri M.D.

Dr. Nikhil Nalluri began at Elite Cardiovascular Group in October 2019 after completing his interventional cardiology fellowship at the renowned Lenox Hill Hospital in New York. He is board certified in interventional cardiology, nuclear cardiology, echocardiography, cardiovascular disease, and internal medicine.

Dr. Nalluri’s passion for research lead him to publish a multitude of research articles throughout the years. He was the lead author for more than 40 publications and earned the ‘Fellow Physician Research Award’ at Hofstra University Northwell Health.

Dr. Nalluri believes that optimal health care is achieved not just by providing the best treatment options but by educating patients on their health conditions and maintaining a healthy lifestyle.

Outside of work he enjoys traveling, photography, hiking, music, and cooking. He is an animal lover and enjoys pampering his dog.

Specializations & Board Certifications
  • American Board of Interventional Cardiology
  • American Board of Cardiovascular Diseases
  • Certification Board of Nuclear Cardiology
  • National Board of Echocardiography
  • American Board of Internal Medicine
Affiliations
  • Methodist Dallas Medical Center
  • Methodist Charlton Medical Center
  • Methodist Mansfield Medical Center
Memberships
  • American College of Cardiology (ACC)
  • Society for Cardiovascular Angiography & Intervention (SCAI)
  • American College of Physicians (ACP)
  • American Medical Association (AMA)
Fellowships
  • Interventional Cardiology at Lenox Hill Hospital, New York
  • Cardiology at Hofstra University Northwell health (SIUH), New York
Residency
  • Chief Resident in Internal Medicine at Staten Island University Hospital, Staten Island, New York
  • Internal Medicine Residency at Staten Island University Hospital, Staten Island, New York
Medical School
  • M.B.B.S at Narayana Medical College, N.T.R. University of Health Sciences, India
Awards
  • Recipient ‘Fellow Physician Research Award’ –  Hofstra University Northwell Health( SIUH)
Research
  • “Dr. Nalluri was wonderful. He explained my condition and what I’m going through very clearly. He also told me why I’m going through it. Dr. Nalluri performed my procedure and was explaining what he is doing every step of the way. He made sure I was comfortable. He also told me about the plan of care I would be getting for the next year. I appreciate him and his care. I’m very happy that I am able to play with my grandkids. Dr. Nalluri had my best interests at heart.”

    Mr. Vincent Paxton
  • “Dr. Nalluri is a wonderful person. He is very professional and has great bedside manners. He treats us like family. He is very knowledgable and is up to date on everything. He is always there for us and goes above and beyond to take care of his patients.”

    Mrs. Lafay, Mr. Michael, & Mrs. Hilda Tolson
  • “Dr. Nalluri takes his job very seriously and that is why he is very respected in his profession. He is a kind and caring person who does good for his patients. I am glad he is my doctor because I have come a mighty long way under his care.”

    Mr. Derrick Davis
  • “Dr. Nalluri did an excellent job with my procedure at the hospital and at the follow-up visits. He explained everything thoroughly and I was pleased with his care.”

    Mr. Anthony Kraut

Publications

  1. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future
  2. Gender, Race, and Health Insurance Status in Patients Undergoing Catheter Ablation for Atrial Fibrillation
  3. Diabetes Insipidus: A Challenging Diagnosis with New Drug Therapies
  4. Valve in valve transcatheter aortic valve implantation (ViV‐TAVI) versus redo—Surgical aortic valve replacement (redo‐SAVR): A systematic review and meta‐analysis
  5. Gender, racial, and health insurance differences in the trend of implantable cardioverter‐defibrillator (ICD) utilization: A United States experience over the last decade
  6. Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a cross-sectional US experience
  7. Biodegradable polymer stents vs second generation drug eluting stents: a meta-analysis and systematic review of randomized controlled trials
  8. Temporal trends, predictors, and outcomes of in-hospital gastrointestinal bleeding associated with percutaneous coronary intervention
  9. Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease
  10. Seasonal variation of acute myocardial infarction related hospitalizations in the United States: perspective over the last decade
  11. Large embolus in transit – An unresolved therapeutic dilemma (case report and review of literature)
  12. Seasonal trends of heart failure hospitalizations in the United States: a national perspective from 2000 to 2011
  13. Subclinical leaflet thrombosis following transcatheter aortic valve replacement
  14. Seasonal Variations and Trends in Hospitalization for Peptic Ulcer Disease in the United States: A 12-Year Analysis of the Nationwide Inpatient Sample
  15. Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight
  16. Primary intimal sarcoma of the left atrium: an incidental finding on routine echocardiography
  17. New-onset lone atrial fibrillation in pregnancy
  18. Temporal Trends in Utilization of Right-Sided Heart Catheterization Among Percutaneous Ventricular Assist Device Recipients in Acute Myocardial Infarction Complicated by Cardiogenic Shock
  19. Drug-eluting stents versus bare-metal stents in saphenous vein graft intervention: an updated meta-analysis of randomized controlled trials
  20. Metabolic syndrome and its impact on cardiovascular diseases
  21. Frequency of 30-day readmission and its causes after endovascular aneurysm intervention of abdominal aortic aneurysm (from the Nationwide Readmission Database)
  22. Cardiogenic shock secondary to takotsubo cardiomyopathy in a patient with preexisting hypertrophic obstructive cardiomyopathy
  23. Effect of ranolazine on the incidence of atrial fibrillation following cardiac surgery
  24. Propensity matched comparison of in‐hospital outcomes of TAVR vs. SAVR in patients with previous history of CABG: Insights from the Nationwide inpatient sample
  25. Non-influence of lipid lowering therapy in atrial fibrillation recurrence
  26. Temporal Trends of In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in United States
  27. Facial Paralysis and Hearing Loss: A Rare Manifestation of Prostate Cancer Metastases
  28. Conduction riddles of Lyme carditis: a case series
  29. Comparison of nationwide trends in 30-day readmission rates after carotid artery stenting and carotid endarterectomy
  30. TCT-125 Impact of Insurance on Outcomes and Readmission Rates in Young Adults After Acute Myocardial Infarction
  31. Transcatheter aortic valve replacement in Bicuspid Aortic Valve Disease: An Insight
  32. Left internal mammary artery to pulmonary artery fistula causing coronary steal syndrome: A review of literature on therapy, intervention, and management
  33. Meta-Analysis of Rotational Atherectomy versus Modified Balloons for the Treatment of De Novo Calcified Coronary Lesions
  34. SAFETY AND EFFICACY OF MITRACLIP IN FUNCTIONAL VERSUS DEGENERATIVE MITRAL REGURGITATION: A META-ANALYSIS OF OBSERVATIONAL STUDIES
  35. THIRTY-DAY READMISSION RATES OF CAROTID ENDARTERECTOMY VERSUS CAROTID ARTERY STENTING: A NATIONWIDE ANALYSIS
  36. SHORT TERM READMISSIONS AFTER PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE NATIONWIDE READMISSION DATABASE OVER A PERIOD OF 5 YEARS
  37. Patterns of Acute Myocardial Infarction in Taiwan from 2009 to 2015……………………. 1996 Cheng-Han Lee, Ching-Chang Fang, Liang-Mifflin Tsai
  38. Trends in Prevalence and Percutaneous Coronary Intervention Utilization Among Patients With Anomalous Coronary Artery
  39. Interventional Approach to Left Main Coronary Artery Dissection
  40. TCT-680 Trends and predictors of early readmission in STEMI patients undergoing multivessel percutaneous coronary intervention
  41. TCT-200 Surgical Left Atrial Appendage Occlusion During Cardiac Surgery: A Systematic Review and Meta-analysis
  42. TCT-178 Temporal trends in the utilization of Right Heart Catheterization (RHC) among recipients of Percutaneous Ventricular Assist Device (PVAD) in Acute Myocardial Infarction complicated by Cardiogenic Shock (AMI-CS)
  43. TCT-87 Thirty-Day Readmission Rate & Etiologies after Endovascular Repair of Abdominal Aortic Aneurysm: A Nationwide Analysis
  44. CORONARY STEAL SYNDROME DUE TO LEFT INTERNAL MAMMARY INTERCOSTAL BRANCH: IMPROVED WITH COILING
  45. EFFECT OF HOSPITAL VOLUME ON TRANSCATHETER MITRAL VALVE REPAIR (TMVR) OUTCOMES: A NATIONWIDE INPATIENT SAMPLE ANALYSIS
  46. TEMPORAL TRENDS IN THE UTILIZATION OF MECHANICAL CARDIAC SUPPORT (MCS) IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): A NATIONWIDE INPATIENT SAMPLE ANALYSIS
  47. VALVE IN VALVE TRANSCATHETER AORTIC VALVE IMPLANTATION VERSUS REDO SURGICAL AORTIC VALVE REPLACEMENT IN FAILING BIOPROSTHETIC VALVES: AN UPDATED META-ANALYSIS
  48. Reverse Takotsubo Cardiomyopathy Following Exploratory Laparotomy
  49. Trends in Outcomes Associated With Percutaneous Coronary Interventions on Bifurcation Lesions
  50. Transcatheter Aortic Valve Implantation Outcomes in Patients With History of Previous Cardiac Surgery: A National in Patient Sample Analysis
  51. Etiologies and Trends of Readmission in Patients With Takotsubo Cardiomyopathy
  52. TCT-531 Statin Therapy and Change in Fibrous Cap Thickness: Meta-Analysis of Optical Coherence Tomography Assessment
  53. TCT-343 Valve in Valve Trans-catheter Aortic Valve Implantation Versus Redo Surgical Aortic Valve replacement in patients with failing aortic bioprostehsis: A Meta Analysis
  54. TCT-519 TAVI versus SAVR in Patients with a History of Previous Cardiac Surgery: A National Inpatient Sample Database Analysis
  55. IgG4-related Disease Presenting as a Pancreatic Mass and Bilateral Lacrimal Gland Swelling
  56. Drug-Eluting Balloon versus Standard Balloon Angioplasty for Infrapopliteal Arterial Disease: Meta-Analysis of Randomized Control Trials
  57. PREDICTORS OF IN-HOSPITAL GASTROINTESTINAL BLEEDING FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES
  58. Trends and Predictors of Acute Myocardial Infarction in HIV Population: A-072
  59. Regional Variation in Management and Outcomes of ST-Elevation Myocardial Infarction with Cardiogenic Shock across the United States: B-072
  60. Seasonal Variation in Peptic Ulcer Disease Hospitalization: A 10-year Perspective in the US: 2315
  61. Median Household, Racial, and Insurance Disparities in Endoscopic Retrograde Cholangiopancreatography (ERCP) 2341
  62. In-Hospital Temporal Trends in Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention in the United States Between 2006 and 2011: Analysis of 3,873,200 Procedures 2317
  63. Utilization Trends of Endoscopic Retrograde Cholangiopancreatography (ERCP) in the United States: A Perspective of the Last Decade: 2288
  64. UTILIZATION AND SAFETY OF CARDIAC RESYNCHRONIZATION THERAPY IN ELDERLY
  65. TRENDS IN ATRIAL FIBRILLATION HOSPITALIZATION IN YOUNG PATIENTS
  66. Acute Myocarditis in a Patient Using Testosterone Diagnosed by Cardiac MRI 
  67. Biodegradable polymer drug eluting stents vs. first generation drug eluting stents: a meta-analysis of randomized controlled trials: D-012
  68. ARE BIODEGRADABLE POLYMER DRUG-ELUTING STENTS THE FUTURE? A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
  69. TCT-180 Incidence and Outcomes of Cardiogenic Shock Complicating Inferior versus Anterior ST-elevation Myocardial Infarction
  70. TCT-179 Trends and Outcomes in the Treatment of Cardiogenic Shock and Use of Mechanical Circulatory Support in The United States